The rest is here:
Israel-Based Clearmind Announces Additional Positive Results from the Third Part of its Pre-Clinical Study for Cocaine Addiction Treatment
Author Archives: Fredricko
AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center
Assertio Announces Partnership with the Lennox-Gastaut Syndrome (LGS) Foundation
Go here to see the original:
Assertio Announces Partnership with the Lennox-Gastaut Syndrome (LGS) Foundation
Living Carbon raises new funding to plant 4M fast-growing, carbon-guzzling supertrees in US
Hillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference on January 18-19, 2023
Transactions in connection with share buy-back program
Here is the original post:
Transactions in connection with share buy-back program
NFL Biosciences: Financial calendar for the first half of 2023
Read the rest here:
NFL Biosciences: Financial calendar for the first half of 2023
AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for DEA License to Work With Controlled Substance
Sanofi: Information concerning the total number of voting rights and shares – December 2022
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
Read the original here:
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor Conference
Beyond Air® Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast
Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National Exchange
Kinnate Biopharma Inc. to Present Trials in Progress Poster for its Pan-FGFR Inhibitor, KIN-3248, at the 2023 ASCO Gastrointestinal Cancers Symposium…
Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference
New Approaches to Treating Infections in Cystic Fibrosis Patients – AR 501 Phase 2 Trial Update
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Burning Rock provides an update on 2022 revenue guidance
Read more here:
Burning Rock provides an update on 2022 revenue guidance